CR9857A - Composiciones de suplemento de hierro con tolerancia mejorada - Google Patents

Composiciones de suplemento de hierro con tolerancia mejorada

Info

Publication number
CR9857A
CR9857A CR9857A CR9857A CR9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A CR 9857 A CR9857 A CR 9857A
Authority
CR
Costa Rica
Prior art keywords
iron
improved tolerance
supplement compositions
iron supplement
effective amount
Prior art date
Application number
CR9857A
Other languages
English (en)
Inventor
Krebs Peter
Kreb-Bensch Allison
Mincy Jerome
Original Assignee
Grace Procurements Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37902204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9857(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grace Procurements Llc filed Critical Grace Procurements Llc
Publication of CR9857A publication Critical patent/CR9857A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a las composiciones y metodos para el tratamiento o profilaxis de la deficiencia de hierro, y en particular, de la anemia causada por la deficiencia de hierro, mediante la administracion de una composicion que contiene una cantidad eficaz de una sal de hierro ferrosa farmaceuticamente aceptable, y una cantidad eficaz de un complejo de polisacarido de hierro.
CR9857A 2005-10-04 2008-04-01 Composiciones de suplemento de hierro con tolerancia mejorada CR9857A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/243,043 US20070077313A1 (en) 2005-10-04 2005-10-04 Toleration iron supplement compositions

Publications (1)

Publication Number Publication Date
CR9857A true CR9857A (es) 2008-07-29

Family

ID=37902204

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9857A CR9857A (es) 2005-10-04 2008-04-01 Composiciones de suplemento de hierro con tolerancia mejorada

Country Status (10)

Country Link
US (2) US20070077313A1 (es)
EP (1) EP1945032A4 (es)
CA (1) CA2624619C (es)
CR (1) CR9857A (es)
CU (1) CU23776B7 (es)
EC (1) ECSP088348A (es)
HN (1) HN2008000582A (es)
SV (1) SV2009002862A (es)
TW (1) TWI358299B (es)
WO (1) WO2007044180A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) * 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
CN102167752B (zh) * 2011-05-23 2012-08-08 华南理工大学 一种水溶性大豆多糖亚铁配合物的制备方法
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
US20240366657A1 (en) * 2021-03-26 2024-11-07 Alberta Veterinary Laboratories Ltd. Water-based iron supplement formulations for dosing animal neonates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
WO2000061191A2 (en) * 1999-04-09 2000-10-19 Advanced Magnetics, Inc. Heat stable coated colloidal iron oxides
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
DE60335426D1 (de) * 2002-08-15 2011-01-27 Euro Celtique Sa Pharmazeutische Zusammensetzungen enthaltend einen Opioidantagonisten
WO2005092441A2 (en) * 2004-03-19 2005-10-06 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia

Also Published As

Publication number Publication date
CA2624619C (en) 2018-03-13
SV2009002862A (es) 2009-01-27
HN2008000582A (es) 2011-11-09
CU20080054A7 (es) 2010-08-30
TWI358299B (en) 2012-02-21
WO2007044180A3 (en) 2007-07-12
EP1945032A2 (en) 2008-07-23
ECSP088348A (es) 2008-07-30
EP1945032A4 (en) 2009-04-15
US20070077313A1 (en) 2007-04-05
CU23776B7 (es) 2012-02-15
CA2624619A1 (en) 2007-04-19
WO2007044180A2 (en) 2007-04-19
US20110052722A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
CR9857A (es) Composiciones de suplemento de hierro con tolerancia mejorada
PE20061122A1 (es) Composiciones que incluyen hierro
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
BR112015018663A2 (pt) derivados de piridazinona-amidas
UA103614C2 (uk) Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
SMT201300096B (it) Inibitori di prolil idrossilasi
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CR11418A (es) Trans-clomifeno para el sindrome metabolico
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
AR089269A1 (es) Composiciones para el cuidado oral
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
TW200700071A (en) Novel use
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
TW200726460A (en) Anti-fatigue composition
DE502005006427D1 (de) Substituierte azachinazoline mit antiviraler wirkung
HN2008001531A (es) Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia
GT200900139A (es) Metodos para el tratamiento del abuso, adiccion y dependencia del alcohol
MX2010004859A (es) Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.
CA2610046A1 (en) Antimicrobial composition useful for preserving wood
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
ATE437624T1 (de) Topische zusammensetzungen
ECSP088897A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización
ECSP088650A (es) Compuestos de amido y su uso como productos farmaceuticos